Eylea Market Size, Competitors, Trends & Forecast to 2032

The Eylea market is experiencing steady and significant transformation amid evolving clinical practices, technology innovations, and global policy changes. Senior decision-makers require actionable intelligence to safeguard access, optimize outcomes, and refine commercial strategies in this dynamic environment.

Market Snapshot: Eylea Market Size and Growth Trends

The Eylea market expanded from USD 7.71 billion in 2025 to USD 8.19 billion in 2026 and is set to grow at a CAGR of 7.45%, reaching USD 12.75 billion by 2032. This trajectory is shaped by continued integration into retinal disease management across diverse indications, robust adoption by providers and payers, and ongoing adaptation to regulatory and supply chain variables.

Scope & Segmentation

Therapeutic Indications: Age-Related Macular Degeneration, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy.
Provider Types: Ambulatory surgical centers, hospitals, and ophthalmic clinics, each with unique operational and procurement dynamics.
Distribution Pathways: Hospital and specialty pharmacies, online channels, retail pharmacy environments all influence access and delivery models.
Dosing Schedules: As Needed, Bimonthly, and Monthly regimens, with implications for patient adherence and clinic capacity.
Regional Focus: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with distinct regulatory, reimbursement, and delivery landscapes.
Technology Landscape: Long-acting formulations, next-generation biologics, intraocular implants, remote monitoring, and teleophthalmology drive ongoing differentiation.

Key Takeaways: Strategic Insights for Stakeholders

Eylea remains central in retinal therapeutics due to its established mechanism of action and broad clinical acceptance, but access is now influenced by innovation from competing therapies and emerging delivery platforms.
Providers and payers increasingly emphasize outcome-driven treatment protocols and evidence generation, elevating the importance of real-world data and health economic analysis in decision-making.
Sourcing and distribution strategies are being reshaped by modernized supply chains, regulatory scrutiny, and geopolitical factors, requiring greater transparency and adaptability among all market participants.
Regional variation in reimbursement, procurement, and clinical infrastructure means access and adoption strategies must be highly tailored to individual market conditions.
Digital health adoption and advanced analytics tools are beginning to reduce patient management friction and support predictive inventory, programmatic adherence, and optimized resource utilization.

Tariff Impact: Supply Chain and Commercial Shifts

United States tariff measures introduced in 2025 directly disrupted the ophthalmic pharmaceutical supply chain. Manufacturers absorbed increased costs for key inputs and accelerated the use of nearshoring and secondary suppliers. Health systems, distributors, and provider organizations adopted new inventory and contracting protocols to minimize risk and maintain supply continuity. Payers responded by tightening scrutiny of reimbursement processes, prompting a shift toward value-based documentation and risk-sharing contracts. The result is a broader expectation for adaptable supply frameworks and explicit risk provisions across key agreements.

Methodology & Data Sources

This report is anchored in mixed-methods research, including interviews with clinical and supply chain leaders, document and literature review, and scenario analysis. Data was validated through triangulation with real-world cases and advisory input from practicing retinal specialists for rigorous, actionable conclusions.

Why This Report Matters

Delivers nuanced, segmented insights by indication, provider type, and region, enabling targeted strategies to optimize clinical, operational, and commercial outcomes.
Equips manufacturers, providers, and payers with scenario-driven recommendations to strengthen supply resilience, adapt to policy shifts, and preserve access under cost and regulatory pressure.

Conclusion

Navigating the Eylea market requires coordinated clinical, commercial, and operational responses. Aligning evidence, supply chain flexibility, and adaptive contracting will position stakeholders to manage evolving challenges and capture new opportunities in retinal therapeutics.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Eylea Market, by Indication

8.1. Age-Related Macular Degeneration
8.2. Branch Retinal Vein Occlusion
8.3. Central Retinal Vein Occlusion
8.4. Diabetic Macular Edema
8.5. Diabetic Retinopathy

9. Eylea Market, by Dosage Frequency

9.1. As Needed
9.2. Bimonthly
9.3. Monthly

10. Eylea Market, by End User

10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Ophthalmic Clinics

11. Eylea Market, by Distribution Channel

11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.3. Retail Pharmacy

12. Eylea Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Eylea Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Eylea Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Eylea Market
16. China Eylea Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc
17.6. Adverum Biotechnologies Inc
17.7. Alcon Inc
17.8. Amgen Inc
17.9. Apellis Pharmaceuticals Inc
17.10. AstraZeneca plc
17.11. Bausch Health Companies Inc
17.12. Bayer AG
17.13. Biogen Inc
17.14. Eli Lilly and Company
17.15. Genentech Inc
17.16. GlaxoSmithKline plc
17.17. Johnson & Johnson
17.18. Kodiak Sciences Inc
17.19. Merck & Co., Inc.
17.20. Novartis AG
17.21. Ono Pharmaceutical Co., Ltd
17.22. Outlook Therapeutics Inc
17.23. Pfizer Inc
17.24. Regeneron Pharmaceuticals Inc
17.25. Roche Holding AG
17.26. Samsung Bioepis Co., Ltd
17.27. Sanofi S.A.
17.28. Santen Pharmaceutical Co., Ltd
17.29. Takeda Pharmaceutical Company Limited

List of Figures

FIGURE 1. GLOBAL EYLEA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL EYLEA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL EYLEA MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL EYLEA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EYLEA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL EYLEA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES EYLEA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA EYLEA MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL EYLEA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EYLEA MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EYLEA MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EYLEA MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EYLEA MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL EYLEA MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL EYLEA MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EYLEA MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EYLEA MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EYLEA MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EYLEA MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EYLEA MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EYLEA MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EYLEA MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EYLEA MARKET SIZE, BY DIABETIC RETINOPATHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EYLEA MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EYLEA MARKET SIZE, BY AS NEEDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EYLEA MARKET SIZE, BY AS NEEDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EYLEA MARKET SIZE, BY AS NEEDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EYLEA MARKET SIZE, BY BIMONTHLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EYLEA MARKET SIZE, BY BIMONTHLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EYLEA MARKET SIZE, BY BIMONTHLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EYLEA MARKET SIZE, BY MONTHLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL EYLEA MARKET SIZE, BY MONTHLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EYLEA MARKET SIZE, BY MONTHLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EYLEA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EYLEA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EYLEA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EYLEA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EYLEA MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EYLEA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EYLEA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EYLEA MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EYLEA MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL EYLEA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL EYLEA MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL EYLEA MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EYLEA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EYLEA MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EYLEA MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EYLEA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL EYLEA MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EYLEA MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL EYLEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS EYLEA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. EUROPE EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. EUROPE EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 71. EUROPE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 72. EUROPE EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. EUROPE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. MIDDLE EAST EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. MIDDLE EAST EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 76. MIDDLE EAST EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. AFRICA EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 81. AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 82. AFRICA EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL EYLEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. ASEAN EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. ASEAN EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 92. ASEAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 93. ASEAN EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. ASEAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. GCC EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GCC EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 97. GCC EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 98. GCC EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. GCC EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. EUROPEAN UNION EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. EUROPEAN UNION EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 102. EUROPEAN UNION EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 103. EUROPEAN UNION EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. EUROPEAN UNION EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. BRICS EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. BRICS EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 107. BRICS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 108. BRICS EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. BRICS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. G7 EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. G7 EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 112. G7 EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 113. G7 EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. G7 EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. NATO EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. NATO EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 117. NATO EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 118. NATO EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. NATO EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. UNITED STATES EYLEA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 122. UNITED STATES EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 123. UNITED STATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 124. UNITED STATES EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. UNITED STATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. CHINA EYLEA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 127. CHINA EYLEA MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 128. CHINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 129. CHINA EYLEA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. CHINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Eylea market report include:

AbbVie Inc
Adverum Biotechnologies Inc
Alcon Inc
Amgen Inc
Apellis Pharmaceuticals Inc
AstraZeneca plc
Bausch Health Companies Inc
Bayer AG
Biogen Inc
Eli Lilly and Company
Genentech Inc
GlaxoSmithKline plc
Johnson & Johnson
Kodiak Sciences Inc
Merck & Co., Inc.
Novartis AG
Ono Pharmaceutical Co., Ltd
Outlook Therapeutics Inc
Pfizer Inc
Regeneron Pharmaceuticals Inc
Roche Holding AG
Samsung Bioepis Co., Ltd
Sanofi S.A.
Santen Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited

Table Information

Report Attribute	Details
No. of Pages	196
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 8.19 Billion
Forecasted Market Value ( USD ) by 2032	$ 12.75 Billion
Compound Annual Growth Rate	7.4%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3450EUR$3,939USD£2,994GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3721EUR$4,249USD£3,230GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5044EUR$5,759USD£4,378GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6104EUR$6,969USD£5,298GBP

Eylea Market - Global Forecast 2026-2032

Market Snapshot: Eylea Market Size and Growth Trends

Scope & Segmentation

Key Takeaways: Strategic Insights for Stakeholders

Tariff Impact: Supply Chain and Commercial Shifts

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Eylea Market Size and Growth Trends

Scope & Segmentation

Key Takeaways: Strategic Insights for Stakeholders

Tariff Impact: Supply Chain and Commercial Shifts

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Eylea: Market Share, and Growth Analysis by Product Type (Injection, Intravitreal Implant), Application, End User, Technology

Eylea HD Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Eylea Market Report 2025

Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Placenta Growth Factor Inhibitors - Pipeline Insight, 2025

About the Eylea Market